tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ELOX Stock Latest News

Eloxx Pharmaceuticals Provides Pipeline and Financing Updates
Press ReleasesEloxx Pharmaceuticals Provides Pipeline and Financing Updates
7d ago
ELOX
Eloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program Updates
PremiumPress Releases
Eloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program Updates
3M ago
ELOX
Eloxx Pharmaceuticals provides ELX-02, ZKN-013 program updates
PremiumThe Fly
Eloxx Pharmaceuticals provides ELX-02, ZKN-013 program updates
3M ago
ELOX
Eloxx Pharmaceuticals treatment of Alport Syndrome granted FDA orphan status
PremiumThe Fly
Eloxx Pharmaceuticals treatment of Alport Syndrome granted FDA orphan status
3M ago
ELOX
Eloxx Pharmaceuticals CEO Stock Option Repricing Initiative
PremiumCompany Announcements
Eloxx Pharmaceuticals CEO Stock Option Repricing Initiative
4M ago
8K
ELOX
Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to license ZKN-013 for rare dermatological diseases
PremiumPress ReleasesAlmirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to license ZKN-013 for rare dermatological diseases
4M ago
ELOX
Eloxx Pharmaceuticals (ELOX) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Eloxx Pharmaceuticals (ELOX) Q4 Earnings Cheat Sheet
5M ago
ELOX
Eloxx Pharmaceuticals files to sell 778,646 shares of common stock for holders
PremiumThe Fly
Eloxx Pharmaceuticals files to sell 778,646 shares of common stock for holders
6M ago
ELOX
Eloxx Pharmaceuticals Reports Third Quarter 2023 Financial and Operating Results and Provides Business Update
PremiumPress Releases
Eloxx Pharmaceuticals Reports Third Quarter 2023 Financial and Operating Results and Provides Business Update
8M ago
ELOX
ELOX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ELOX Earnings this Week: How Will it Perform?
8M ago
ELOX
Eloxx Pharmaceuticals price target lowered to $30 from $60 at Oppenheimer
PremiumThe Fly
Eloxx Pharmaceuticals price target lowered to $30 from $60 at Oppenheimer
9M ago
ELOX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
9M ago
ALDX
APLT
Eloxx Pharmaceuticals reports results of patient biopsy assessment by NIPOKA
PremiumThe FlyEloxx Pharmaceuticals reports results of patient biopsy assessment by NIPOKA
9M ago
ELOX
Eloxx Pharmaceuticals Reports Additional Confirmation that All Nonsense Mutation Alport Syndrome Patients Treated with ELX-02 in Phase 2 Study had Improvement in Kidney Morphology and Clinical Benefit of Reduction or Stabilization of Proteinuria
PremiumPress Releases
Eloxx Pharmaceuticals Reports Additional Confirmation that All Nonsense Mutation Alport Syndrome Patients Treated with ELX-02 in Phase 2 Study had Improvement in Kidney Morphology and Clinical Benefit of Reduction or Stabilization of Proteinuria
9M ago
ELOX
Eloxx Pharmaceuticals Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
PremiumPress Releases
Eloxx Pharmaceuticals Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
10M ago
ELOX
Eloxx reports independent confirmation of TEM assessment results
PremiumThe Fly
Eloxx reports independent confirmation of TEM assessment results
10M ago
ELOX
Eloxx Pharmaceuticals Provides Program Updates on ELX-02 and ZKN-013
PremiumPress Releases
Eloxx Pharmaceuticals Provides Program Updates on ELX-02 and ZKN-013
11M ago
ELOX
Eloxx Pharmaceuticals provides updates on ELX-02, ZKN-013
PremiumThe Fly
Eloxx Pharmaceuticals provides updates on ELX-02, ZKN-013
11M ago
ELOX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
11M ago
BTAI
ELOX
Eloxx Pharma (NASDAQ:ELOX) Rises on Promising Phase 2 Data in Alport Syndrome
PremiumMarket NewsEloxx Pharma (NASDAQ:ELOX) Rises on Promising Phase 2 Data in Alport Syndrome
11M ago
ELOX
Eloxx Pharmaceuticals Reports Second Quarter 2023 Financial and Operating Results and Provides Business Update
PremiumPress Releases
Eloxx Pharmaceuticals Reports Second Quarter 2023 Financial and Operating Results and Provides Business Update
11M ago
ELOX
Eloxx Pharmaceuticals reports Q2 EPS ($1.96) vs ($4.90) last year
PremiumThe Fly
Eloxx Pharmaceuticals reports Q2 EPS ($1.96) vs ($4.90) last year
11M ago
ELOX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >